Your browser doesn't support javascript.
loading
Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial).
Christ, Lisa; Gloor, Andrea D; Kollert, Florian; Gaber, Timo; Buttgereit, Frank; Reichenbach, Stephan; Villiger, Peter M.
Affiliation
  • Christ L; Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gloor AD; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Kollert F; Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gaber T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Buttgereit F; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Reichenbach S; Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Villiger PM; University of Bern, Institute for Social and Preventive Medicine, Bern, Switzerland.
Front Immunol ; 14: 1165758, 2023.
Article in En | MEDLINE | ID: mdl-37287970
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: